What is the recommended operative and peri‑operative approach for a robotic‑assisted total laparoscopic hysterectomy with bilateral salpingectomy, possible salpingo‑oophorectomy, intra‑operative cystoscopy, and potential conversion to laparotomy?

Robotic-Assisted Total Laparoscopic Hysterectomy with Bilateral Salpingectomy

Robotic-assisted minimally invasive surgery is the preferred surgical approach for this procedure, offering comparable oncologic outcomes to traditional laparoscopy with potential advantages in reduced blood loss, lower conversion rates, and shorter hospital stays 1, 2.

Surgical Approach Selection

The robotic platform should be your primary choice when technically feasible, particularly for:

• Patients with obesity or elevated BMI (conversion rates: 4.9% robotic vs 9.9% laparoscopic) 3
• Complex anatomy requiring enhanced dexterity
• Patients at higher anesthesiologic risk 2

Minimally invasive surgery (robotic or laparoscopic) is explicitly recommended over laparotomy for all patients, including those with high-risk disease 1. Laparotomy should be reserved only for specific situations: very large uteri, elderly patients with prohibitive comorbidities, or confirmed metastatic presentations requiring open debulking 2.

Operative Technique Components

Hysterectomy and Bilateral Salpingectomy

• Perform total hysterectomy with bilateral salpingectomy as standard 1
• Avoid intraperitoneal morcellation; remove the uterus en bloc 2
• For premenopausal patients <45 years with FIGO 2023 IA1/IA2 low-risk disease by molecular classification, ovarian preservation may be considered, but bilateral salpingectomy remains mandatory 1
• Do not preserve ovaries in patients with hereditary risk (BRCA, Lynch syndrome carriers) 1

Lymph Node Assessment

If staging is indicated (presumed uterus-confined endometrial cancer):

• Sentinel lymph node biopsy using indocyanine green with cervical injection is the preferred detection technique 1
• Consider tracer re-injection if sentinel nodes not visualized initially 1
• If sentinel nodes not detected on either pelvic side, perform side-specific systematic lymphadenectomy for high-intermediate or high-risk patients 1
• All sentinel lymph nodes require ultrastaging with at least two additional sectioning levels (50-250µ apart) 1

Robotic approach yields adequate lymph node retrieval: pooled means of 18.5 pelvic nodes and 10.3 aortic nodes, comparable to laparoscopy 3.

Intraoperative Cystoscopy

Perform cystoscopy at case completion to:

• Confirm ureteral patency bilaterally
• Exclude bladder injury (injury rates similar across all approaches: ~1-2%) 3
• Document findings before leaving the operating room

Perioperative Considerations

Expected Outcomes

• Operative time: Similar to laparoscopy (approximately 11.8 minutes longer than laparoscopy, but this difference is not clinically significant) 4
• Blood loss: Significantly reduced compared to laparotomy (mean difference -17.81 mL vs laparoscopy) 3, 4
• Hospital stay: 0.64 days shorter than conventional laparoscopy 4; expect discharge on postoperative day 1 in 94% of cases 5
• Conversion rate: 4.9% for robotic vs 9.9% for laparoscopic approaches 3

Complication Monitoring

Complication rates are equivalent across minimally invasive approaches 3, 4:

• Vascular, bowel, and bladder injuries: 1-2%
• Vaginal cuff dehiscence: <1%
• Thromboembolic events: <1%
• Transfusion requirements: 1.7-2.6%

Conversion to Laparotomy Planning

Have laparotomy capability immediately available for:

• Poor visibility despite pneumoperitoneum optimization
• Uncontrolled bleeding
• Discovery of extensive metastatic disease requiring debulking
• Dense adhesions preventing safe dissection

The robotic platform reduces conversion likelihood compared to traditional laparoscopy, particularly in obese patients 2, 3.

Common Pitfalls to Avoid

1. Morcellation error: Never perform intraperitoneal morcellation; always remove specimens intact through vaginal extraction or contained bag extraction 2

2. Inadequate lymph node assessment: If sentinel nodes are not detected, you must perform systematic lymphadenectomy on that side for appropriate-risk patients—do not skip this step 1

3. Ovarian preservation in high-risk genetics: Always screen for hereditary cancer syndromes before preserving ovaries; preservation is contraindicated in BRCA and Lynch syndrome carriers 1

4. Skipping cystoscopy: Universal cystoscopy is essential given the 1-2% bladder injury rate that may be occult 3